發(fā)布時(shí)間：2018-06-17 02:05

  本文選題：藥品價(jià)格 + 價(jià)格形成機(jī)制��； 參考：《中國藥房》2017年24期

【摘要】：目的:為我國制定合理的藥品醫(yī)保支付價(jià)格提供借鑒。方法:通過檢索分析國內(nèi)外正式發(fā)表的學(xué)術(shù)文章、官方網(wǎng)站和政府文件、新聞報(bào)道等資料和知情人訪談,總結(jié)國際主要藥品醫(yī)保支付價(jià)格形成機(jī)制,高值藥可持續(xù)的公平可及的解決方式,為我國制定合理的藥品價(jià)格政策提出建議。結(jié)果與結(jié)論:國際通用的醫(yī)藥支付價(jià)格的確定依據(jù)為內(nèi)部參考定價(jià)法、增量成本-效果評(píng)價(jià)法、外部參考定價(jià)法。國際社會(huì)還采取以公平藥價(jià)計(jì)劃、藥品專利池、開源藥物研發(fā)組織等形式促進(jìn)高值藥可持續(xù)地公平可及。我國實(shí)現(xiàn)全民醫(yī)保目標(biāo)后,應(yīng)積極探索制定合理的醫(yī)保支付價(jià)格�？梢栽诜轮扑庂|(zhì)量和臨床療效一致性評(píng)價(jià)后,采用內(nèi)部參考定價(jià)法確定有仿制藥競爭品種的支付標(biāo)準(zhǔn),采用外部參考定價(jià)法或增量成本-效果評(píng)價(jià)法確定創(chuàng)新專利藥品價(jià)格談判的參考價(jià)格,對(duì)高值藥物采用公平定價(jià)的理念。
[Abstract]:Objective: to provide reference for the establishment of reasonable medical insurance payment price in China. Methods: through the retrieval and analysis of published academic articles, official websites and government documents, news reports and interviews with insiders, the formation mechanism of international major drug insurance payment price was summarized. Sustainable, fair and accessible solutions for high-value drugs are proposed for the formulation of reasonable drug price policies in China. Results & conclusion: the international general pricing of pharmaceutical payment is based on internal reference pricing, incremental cost-effect evaluation and external reference pricing. The international community also promotes sustainable and equitable access to high-value drugs in the form of fair drug pricing schemes, drug patent pools, and open source drug research and development organizations. After our country realizes the goal of universal medical insurance, we should actively explore the reasonable medical insurance payment price. After evaluating the consistency between the quality and clinical efficacy of generic drugs, the internal reference pricing method can be used to determine the payment criteria for competing varieties of generic drugs. The external reference pricing method or incremental cost-effect evaluation method is used to determine the reference price of the innovative patent drug price negotiation, and the fair pricing concept for high value drugs is adopted.
【作者單位】： 中國醫(yī)學(xué)科學(xué)院北京協(xié)和醫(yī)學(xué)院公共衛(wèi)生學(xué)院;
【基金】：中央級(jí)公益性科研院所基本科研業(yè)務(wù)費(fèi)項(xiàng)目 國家衛(wèi)生計(jì)生委藥政司委托研究課題(No.藥政[2016]9號(hào))
【分類號(hào)】：R951
，

本文編號(hào)：2029123